ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2026
Bioinformatics Analysis of the Diagnostic Value of Copper and Zinc Metabolism-Related Genes in Major Depressive Disorder: An In Silico Multi-Cohort Study.
Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
This study aimed to identify copper and zinc metabolism-related genes as potential diagnostic biomarkers for major depressive disorder through an integrated multi-cohort bioinformatics analysis. GSE98793 (whole blood) served as the training set, with GSE39653 and GSE52790 (both PBMC) as external validation sets. Platform differences were corrected with ComBat using disease status as a covariate; batch parameters were estimated on the training set alone and applied to the validation cohorts by a frozen reference-batch approach, preventing data leakage. Copper and zinc metabolism-related genes (CZMRGs) were compiled from GeneCards and KEGG, then intersected with differentially expressed genes and WGCNA module genes. Candidates were prioritized by protein-protein interaction analysis and three machine learning algorithms (LASSO, SVM-RFE, random forest), and a logistic regression model was evaluated by ROC, calibration, and decision curve analysis. Of the dual-metal genes shared by the copper and zinc lists, 22.5% fell within the MDD-associated co-expression module, against 17.1% of single-metal genes (Fisher's exact test, OR = 1.41, p = 0.012), indicating modest but significant coupling of the two metal programs. Three genes were selected concordantly by all three algorithms: MT1A, MT2A, and SLC30A1, each significant after false discovery rate correction. The model achieved an AUC of 0.88 (training), 0.81 (Validation-1), and 0.78 (Validation-2), outperforming every individual gene. All three genes remained independently associated with MDD after adjustment for immune cell composition (adjusted AUC 0.84), and all were re-selected under stricter gene-universe thresholds. MT1A, MT2A, and SLC30A1 form a validated, externally reproducible diagnostic panel for MDD, pointing to a coordinated disturbance of copper-zinc buffering, although the specific evidence for copper-zinc coupling beyond general metal-gene enrichment remains modest.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.